Pfizer Q4 net jumps on sale of nutrition business
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. ...
Other
Jan 29, 2013 |
not rated yet |
0
Novartis Q4 net profit rebounds to $2.1 billion
(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year.
Other
Jan 23, 2013 |
not rated yet |
0
J&J 4Q profit jumps on higher sales, lower charges (Update)
Higher sales of prescription drugs and medical devices helped Johnson & Johnson post a much bigger fourth-quarter profit than a year ago, when a slew of charges depressed results.
Other
Jan 22, 2013 |
not rated yet |
0
Price cap regulations for UK tobacco would raise 500 million every year
If tobacco products sold in the UK were subject to price cap regulation, the system would generate around £500 million (US$750 million) for the government every year, without affecting the price consumers pay, reveals a ...
Health
Jan 14, 2013 |
not rated yet |
0
Deal or no deal: 5 year olds make smart decisions in games of risk
You may have to be over a certain age to be a contestant on "Deal or No Deal", but children as young as five start to maximize their profits - in cookies - when making decisions similar to those on the show, according to ...
Psychology & Psychiatry
Jan 09, 2013 |
not rated yet |
0
|
Number of independent physicians continues to decline
(HealthDay)—Physician business models are transforming, with a sustained shift away from independent practice, according to report released by the consulting firm Accenture.
Health
Dec 11, 2012 |
not rated yet |
0
Program to up access to combo malaria therapy successful
(HealthDay)—Implementation of a series of national-scale pilot programs designed to increase the access and use of quality-assured artemisinin-based combination therapies (QAACTs) for malaria by the Affordable ...
Diseases, Conditions, Syndromes
Nov 01, 2012 |
not rated yet |
0
Pfizer 3Q profit falls 14 pct on generic Lipitor (Update)
(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Other
Nov 01, 2012 |
not rated yet |
0
Government can play important role in obesity epidemic
Addressing the obesity epidemic by preventing excess calorie consumption with government regulation of portion sizes is justifiable and could be an effective measure to help prevent obesity-related health problems and deaths, ...
Overweight and Obesity
Sep 18, 2012 |
not rated yet |
0
Diabetes drugs helps boost Novo Nordisk in Q2
(AP) — Danish pharmaceutical company Novo Nordisk A/S says its net profit grew by 29 percent in the second quarter of 2012, chiefly spurred by strong sales of its new diabetes drugs.
Other
Aug 09, 2012 |
not rated yet |
0
Belgian pharmaceuticals giant Solvay posts profit rise
Belgium's pharmaceuticals giant Solvay announced a better-than-expected 6.0 percent rise in net profit for the second quarter on Friday, sending its shares rising sharply.
Other
Jul 27, 2012 |
not rated yet |
0
GlaxoSmithKline profits up on lower tax
British drugmaker GlaxoSmithKline on Wednesday said its second quarter net profit rose 13.3 percent from a year earlier to £1.25 billion ($1.94 billion, 1.59 billion euros).
Other
Jul 25, 2012 |
not rated yet |
0
3Qs: Analyzing why sudden drug shortages occur
Drug manufacturers and the Food and Drug Administration (FDA) scrambled earlier this month to address a sudden shortage of methotrexate, a 60-year-old drug that treats children with severe cases of leukemia ...
Medications
Feb 28, 2012 |
not rated yet |
0
GlaxoSmithKline posts rising Q3 profits
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rose seven percent, boosted by growth across its main pharmaceuticals, vaccines and consumer healthcare divisions.
Other
Oct 26, 2011 |
5 / 5 (1) |
1
Novartis announces 2,000 job losses, profits up
Swiss pharmaceutical giant Novartis announced 2,000 job losses Tuesday, mostly in Switzerland and the United States, while reporting net profits of $3.53 billion (2.5 billion euros) for the third quarter.
Other
Oct 25, 2011 |
5 / 5 (1) |
0
